Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
This protein carries a human IgG1 Fc tag at the C-terminus
The protein has a calculated MW of 92.7 kDa. The protein migrates as 100-120 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
>95% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
Human G-CSF R, Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
Immobilized Human G-CSF Protein, premium grade (Cat. No. GCF-H5214) at 2 μg/mL (100 μL/well) can bind Human G-CSF R, Fc Tag (Cat. No. GCR-H5250) with a linear range of 1-16 ng/mL (QC tested).
Explore our catalog of therapeutic antibody solutions to find the right products for you! We are dedicated to delivering solutions designed to help you drive innovation and push the boundaries of what therapeutic antibodies can be.
We offer a wide range of cell and gene therapy solutions starting from discovery to the clinic. Explore our wide range of proteins, antibodies, kits, and other assays to accelerate the development of your cell and gene therapy.
Organoid Toolbox is a collection of organoid solutions including ready-to-use organoids, organoid differentiation kits, and a variety of services to accelerate the progress of your drug development project.
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2, CD133, GPRC5D,CCR8, CCR5, etc.
A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.
To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.
Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.
Comprehensive cytokine targets including interleukins, growth factors, chemokines, TNFs, etc. are expressed by HEK293 to ensure their natural structure. Their high purity is verified by SDS-PAGE/HPLC/SEC-MALS and high bioactivity is verified by ELISA/SPR/BLI.
Aneuro provides comprehensive tools for neuroscience research, including neuroscience proteins, pre-formed fibrils (PFFs), neural antibodies, neural factors, and more—aiming to accelerate disease modeling, drug screening, and neural mechanism studies.
English Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Pegfilgrastim | R-1471; SD-01; SD/01; KRN-125 | Approved | Kyowa Hakko Kirin Co Ltd, Amgen Inc | Ristempa, Neulasta, G-Lasta, Neulastim | United States | Neutropenia | Amgen Inc | 2002-01-31 | Breast Neoplasms; Carcinoma, Endometrioid; Lung Neoplasms; Endometrial Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoma; Adenocarcinoma, Clear Cell; Prostatic Neoplasms; Carcinoma, Adenosquamous; Sarcoma; Hematopoietic stem cell transplantation (HSCT); Urinary Bladder Neoplasms; Pancreatic Neoplasms; Carcinoma; Stomach Neoplasms; Esophageal Neoplasms; Neutropenia; Head and Neck Neoplasms; Skin Melanoma; Ovarian Neoplasms; Diabetes Mellitus, Type 1 | Details |
Empegfilgrastim | BCD-017 | Approved | BIOCAD JSC | Extimia | Neutropenia | Details | ||||
Pegfilgrastim biosimilar (Coherus BioSciences) | CHS-1701 | Approved | Coherus Biosciences Inc | Udenyca, UDENYCA | United States | Febrile Neutropenia | Coherus Biosciences Inc | 2018-09-21 | Neutropenia; Acute Radiation Syndrome; Febrile Neutropenia | Details |
Filgrastim biosimilar (Institute of Medical Biology Chinese Academy of Medical Sciences) | Approved | Institute Of Medical Biology, Chinese Academy Of Medical Sciences | 吉洛因 | Mainland China | Myelodysplastic Syndromes; Leukopenia | Institute Of Medical Biology, Chinese Academy Of Medical Sciences | 2001-01-01 | Myelodysplastic Syndromes; Leukopenia | Details | |
Pegfilgrastim biosimilar (Hospira) | HSP-130 | Approved | Pfizer Inc, Hospira | Nyvepria | United States | Febrile Neutropenia | Hospira Inc | 2020-06-10 | Neutropenia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, AIDS-Related; Febrile Neutropenia | Details |
Nartograstim | KW-2228; PE-2601; ND-28 | Approved | Kyowa Hakko Kirin Co Ltd | Neu-up | Japan | Neutropenia | Kyowa Hakko Kirin Co Ltd | 1994-04-01 | Neutropenia | Details |
Pegfilgrastim biosimilar (Juta Pharma) | Approved | Juta Pharma | Grasustek | EU | Neutropenia | Juta Pharma Gmbh | 2019-04-26 | Neutropenia | Details | |
Filgrastim biosimilar (Nanogen) | Approved | Nanogen Biopharmaceutical Co | Ficocyte | Vietnam | Neutropenia | Nanogen Biopharmaceutical Co | 2014-01-01 | Neutropenia | Details | |
Filgrastim biosimilar (Blau Pharmaceuticals) | Approved | Blau Pharmaceuticals | Brazil | Neutropenia | Blau Pharmaceuticals | 2012-10-01 | Neutropenia | Details | ||
Filgrastim biosimilar (Accord Healthcare) | Approved | Accord Healthcare | Accofil | EU | Neutropenia | Accord Healthcare Slu | 2014-09-17 | Neutropenia | Details | |
Filgrastim biosimilar (PanPharmaceuticals) | Approved | Harvest Moon | India | Febrile Neutropenia | null | 2012-01-01 | Febrile Neutropenia | Details | ||
Filgrastim biosimilar (Biosidus) | Approved | Biosidus | Neutromax, Granulostim | Neutropenia | Details | |||||
Filgrastim biosimilar (Biocon) | Approved | Biocon Biopharmaceuticals | Nufil | India | Neutropenia | null | 2008-01-01 | Neutropenia | Details | |
Pegfilgrastim biosimilar (Beijing SL Pharmaceutical) | Approved | Beijing Sl Pharmaceutical Co Ltd | Mainland China | Neutropenia | Beijing Sl Pharmaceutical Co Ltd | 2023-09-19 | Neutropenia | Details | ||
Filgrastim biosimilar (Unilab) | Approved | Unilab | Neocyte | Neutropenia | Details | |||||
Filgrastim biosimilar (GeneScience Pharmaceuticals) | Approved | Changchun GeneScience Pharmaceuticals Co Ltd | Scimax, 金磊赛强 | Mainland China | Neutropenia | Changchun GeneScience Pharmaceuticals Co Ltd | 1998-01-01 | Neutropenia | Details | |
Pegfilgrastim biosimilar (Zydus Cadila) | Approved | Zydus Cadila | India | Neutropenia | Zydus Cadila | 2014-01-01 | Neutropenia | Details | ||
Filgrastim biosimilar (Veropharm) | Approved | Abbott Laboratories | Mielastra | Neutropenia | Details | |||||
Filgrastim | rhGCSF (Amgen/Kyowa Hakko Kirin); r-metHuG-CSF; REC-G-CSF; KRN-8601 | Approved | Amgen Inc, Kyowa Hakko Kirin Co Ltd | Granulokine, Gran, Nugraf, Neupogen, 惠尔血, 优保津, 吉赛欣 | United States | Neutropenia | Amgen Inc | 1991-02-20 | Alzheimer Disease; Pancytopenia; Anemia, Aplastic; Musculoskeletal Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Critical Illness; Malnutrition; Ischemic Stroke; Sickle Cell Trait; Fever; Primary Myelofibrosis; Breast Neoplasms; Colorectal Neoplasms; Leukemia, Myeloid, Chronic-Phase; Lymphoma; Leukemia, Myeloid, Acute; Leg Ulcer; Thrombocytopenia; Ischemia; Leukemia, Myelomonocytic, Juvenile; Respiratory Insufficiency; Crohn Disease; Fanconi Anemia; Leukemia; HIV Infections; Diabetic Foot; Skin Melanoma; Leukemia, Myelogenous, Chronic; Neutropenia; Menopausal symptoms; Liver Cirrhosis; Anemia, Diamond-Blackfan; Dyskeratosis Congenita; Solid tumours; Pancreatic Neoplasms; Graft vs Host Disease; Hot Flashes; Cardiomyopathy, Dilated; Myelodysplastic Syndromes; Myeloproliferative Disorders; Shwachman-Diamond Syndrome; Multiple Myeloma; Uveal melanoma; Neuroblastoma | Details |
Filgrastim biosimilar (Apotex/Intas) | Approved | Apotex, Intas Biopharmaceuticals | Grastofil, SciLocyte, Neukine | India | Neutropenia | null | 2004-01-01 | Neutropenia | Details | |
Pegfilgrastim biosimilar (Harvest Moon Pharmaceuticals/PanPharmaceuticals) | Approved | Harvest Moon | India | Neutropenia | null | 2012-01-01 | Neutropenia | Details | ||
Filgrastim biosimilar (Pharmstandard/Masterclone/CJSC Generium) | Approved | Cjsc Generium, Pharmstandard, Masterclone | Neipomax, Neupomax | Neutropenia | null | 2008-01-01 | Neutropenia | Details | ||
Pegfilgrastim biosimilar (Intas Biopharmaceuticals) | INTP-5 | Approved | Intas Biopharmaceuticals, Apotex | Neupeg, Lapelga, Pegasta | India | Neutropenia | null | 2007-01-01 | Neutropenia; Febrile Neutropenia | Details |
Filgrastim biosimilar (PT Kalbe) | Approved | Kalbe Farma | India | Neutropenia | Kalbe Farma | 2012-08-01 | Neutropenia | Details | ||
Filgrastim biosimilar (Claris Lifesciences) | Approved | Claris Lifesciences Ltd | Fegrast | India | Neutropenia | Claris Lifesciences Ltd | 2012-01-01 | Neutropenia | Details | |
Efbemalenograstim alfa | F-627 | Approved | Evive (Shanghai) Corp Ltd | Bineuta, 亿立舒, Ryzneuta | Mainland China | Neutropenia | Evive Biopharmaceutical (Beijing) Co Ltd | 2023-05-06 | Chemotherapy-Induced Febrile Neutropenia; Neutropenia; Breast Neoplasms; Febrile Neutropenia | Details |
Recombinant human granulocyte colony-stimulating factor (Shandong Kexing Bioproducts Co Ltd) | Approved | Shandong Kexing Bio-Products Co Ltd | 白特喜 | Mainland China | Neutropenia | Shandong Kexing Bio-Products Co Ltd | 2001-01-01 | Neutropenia | Details | |
Filgrastim biosimilar (Apexcela) | SBS-6002; Leuco-Plus-300 | Approved | Apexcela | Neutropenia | Details | |||||
Recombinant human granulocyte colony-stimulating Factor (Shenzhen Xinpeng Bio-tech) | Approved | Shenzhen Sinobioway Xinpeng Biomedicine Co Ltd | 瑞血新 | Mainland China | Neutropenia | Shenzhen Sinobioway Xinpeng Biomedicine Co Ltd | 1999-01-01 | Neutropenia | Details | |
Filgrastim biosimilar (CJ Corp) | Approved | HK inno.N Corporation | Neutropenia | Details | ||||||
Filgrastim biosimilar (Xiamen Amoytop Biotech) | Approved | Xiamen Amoytop Biotech Co Ltd | 特尔津, Topneuter | Mainland China | Neutropenia | Xiamen Amoytop Biotech Co Ltd | 1999-01-01 | Neutropenia | Details | |
Filgrastim biosimilar (Eurofarma) | Approved | Eurofarma | Granulen | Brazil | Neutropenia | Eurofarma | 2012-01-01 | Neutropenia | Details | |
Filgrastim biosimilar (Sedico) | Approved | Sedico | Neutropenia | Details | ||||||
Filgrastim biosimilar (Zenotech Laboratories) | Approved | Zenotech Laboratories | Neoplasms; Neutropenia | Zenotech Laboratories | 2006-03-01 | Neutropenia; Neoplasms | Details | |||
Filgrastim biosimilar (Lupin) | Approved | Lupin Ltd | Lupifil | India | Neutropenia | Lupin Ltd | 2016-01-01 | Neutropenia | Details | |
Filgrastim biosimilar (Beijing SL Pharmaceutical) | Approved | Beijing Sl Pharmaceutical Co Ltd | 立生素, Li Sheng Su | Mainland China | Neutropenia | Beijing Sl Pharmaceutical Co Ltd | 1998-01-01 | Neutropenia | Details | |
Pegfilgrastim biosimilar (Nanogen Biopharmaceutical) | Approved | Nanogen Biopharmaceutical Co | Neutropenia | Details | ||||||
Filgrastim biosimilar (Biolotus Biotech) | Approved | Biolotus | Kymun-CSF | Brazil | Neutropenia | Biolotus | 2016-06-01 | Neutropenia | Details | |
Filgrastim biosimilar (Fresenius Kabi Oncology) | Approved | Fresenius Kabi Ag | India | Neutropenia | Fresenius Kabi Ag | 2012-08-01 | Neutropenia | Details | ||
Tbo-filgrastim | TKN-732; XM-02 | Approved | Teva | Tevagrastim, Biograstim, Granix | EU | Neutropenia | Ratiopharm Gmbh | 2008-09-15 | Hematopoietic stem cell transplantation (HSCT); Neutropenia | Details |
Filgrastim biosimilar (Laboratorios AC Farma) | Approved | Laboratorios Ac Farma | FGM-Factor | Peru | Neutropenia | Laboratorios Ac Farma | 2012-01-01 | Neutropenia | Details | |
Filgrastim biosimilar(Pooyesh Darou Pharmaceuticals) | G-CSF | Approved | Pooyesh Darou | PD-grastim | Neutropenia; Febrile Neutropenia | Details | ||||
Filgrastim biosimilar (Chandra Bhagat Pharma) | Approved | Chandra Bhagat Pharma(Cbc) | Filgen | India | Neoplasms | Chandra Bhagat Pharma(Cbc) | 2012-08-01 | Neoplasms | Details | |
Filgrastim biosimilar (Zydus Cadila) | Approved | Zydus Cadila | India | Neutropenia | Zydus Cadila | 2014-01-01 | Neutropenia | Details | ||
Filgrastim biosimilar (AqVida) | Approved | Aqvida Gmbh | Leucita | Russian Federation | Neutropenia | Aqvida Gmbh | 2008-05-01 | Neutropenia | Details | |
Filgrastim biosimilar (Incepta Pharmaceuticals) | Approved | Incepta Pharmaceuticals Ltd | Neutropenia | Details | ||||||
Pegfilgrastim biosimilar (AryaTinaGene) | Approved | Aryatinagene Biopharmaceuticals | Tinapeg | Febrile Neutropenia | Details | |||||
Recombinant human granulocyte colony-stimulating factor (Shanghai Sunway Biotech) | Approved | Shanghai Sunway Bio Co Ltd | 赛格力, SunGran | Mainland China | Neutropenia | Shanghai Sunway Bio Co Ltd | 1998-01-01 | Neutropenia | Details | |
Filgrastim biosimilar (Laboratorio Varifarma) | Approved | Laboratorio Varifarma | Neutrofil | Neutropenia | Details | |||||
Recombinant human granulocyte colony-stimulating factor (Harbin Pharmaceutical Group Bioengineering) | Approved | Harbin Pharmaceutical Group Holding Co Ltd | 里亚金, Li Ya Jin | Mainland China | Neutropenia | Harbin Pharmaceutical Group Holding Co Ltd | 2000-01-01 | Neutropenia | Details | |
Eflapegrastim | LAPS-GCSF; HNK-460; SPI-2012; HM-10460A | Approved | Hanmi Pharmaceutical Co Ltd | ROLVEDON, Rolontis, Rolvedon, ROLONTIS | South Korea | Neutropenia | Hanmi Pharmaceutical Co Ltd | 2021-03-18 | Solid tumours; Neutropenia; Breast Neoplasms; Lymphoma; Febrile Neutropenia | Details |
Recombinant Human Granulocyte Colony-stimulating Factor (Wuzhong Group) | Approved | Suzhou Pharmaceutical Factory | 洁欣, Jiexin | Mainland China | Neutropenia | Suzhou Pharmaceutical Factory | 1999-01-01 | Neutropenia | Details | |
Filgrastim biosimilar (Chalver Laboratorios) | Approved | Chalver Laboratorios | Leucosos | Colombia | Neutropenia | Chalver Laboratorios | 2012-01-01 | Neutropenia | Details | |
Filgrastim biosimilar (Siam Bioscience) | Approved | Siam Bioscience | Neutropenia | Details | ||||||
Filgrastim biosimilar (Reliance Life Sciences) | Approved | Reliance Life Sciences | ReliGrast | India | Neutropenia | Reliance Life Sciences | 2008-01-01 | Neutropenia | Details | |
Filgrastim biosimilar (Tanvex BioPharma) | TX-01 | Approved | Tanvex Biopharma | NYPOZI | Canada | Febrile Neutropenia | Tanvex Biopharma | 2021-10-17 | Hematopoietic stem cell transplantation (HSCT); Chemotherapy-Induced Febrile Neutropenia; Neutropenia; Febrile Neutropenia | Details |
Recombinant human granulocyte stimulating factor (CSPC Pharma) | Approved | CSPC Pharmaceutical Group Ltd | 津恤力, GeneLeukim | Mainland China | Neutropenia | Cspc Baike (Shandong) Biopharmaceutical Co Ltd | 2000-01-01 | Neutropenia | Details | |
Filgrastim biosimilar (Dong-A) | DA-3030 | Approved | Dong-A Pharmaceutical Co Ltd | Leukostim | South Korea | Neutropenia | Dong-A Pharmaceutical Co Ltd | 1999-01-01 | Drug-Related Side Effects and Adverse Reactions; Neutropenia; Diabetic Neuropathies | Details |
Filgrastim biosimilar (Adello Biologics/KASHIV BIOSCIENCES) | Approved | Adello Biologics Llc | United States | Neutropenia; Febrile Neutropenia; Chemotherapy-Induced Febrile Neutropenia | Kashiv BioSciences LLC | 2022-02-25 | Chemotherapy-Induced Febrile Neutropenia; Neutropenia; Febrile Neutropenia | Details | ||
Pegfilgrastim biosimilar (Amega Biotech) | Approved | Amega Biotech | Neutropenia | Details | ||||||
Filgrastim biosimilar (Hangzhou Jiuyuan Gene Engineering) | Approved | Hangzhou Jiuyuan Gene Engineering Co., Ltd. | 吉粒芬, Jilifen | Mainland China | Neutropenia | Hangzhou Jiuyuan Gene Engineering Co., Ltd. | 1998-04-01 | Neutropenia | Details | |
Filgrastim biosimilar (Probiomed) | Approved | Probiomed | Filatil | Mexico | Neutropenia | Probiomed | 2006-03-01 | Neutropenia | Details | |
Filgrastim biosimilar (Emcure Pharmaceuticals) | Approved | Emcure Pharma | India | Neutropenia | Emcure Pharma | 2013-01-01 | Neutropenia | Details | ||
Mecapegfilgrastim (Hengrui) | HHPG-19K | Approved | Jiangsu Hengrui Medicine Co Ltd | 艾多 | Mainland China | Neutropenia | Jiangsu Hengrui Medicine Co Ltd | 2018-05-08 | Neutropenia; Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Febrile Neutropenia | Details |
Filgrastim biosimilar (Hospira) | PLD-108 | Approved | Hospira | Nivestim, Nivestym | EU | Hematopoietic stem cell transplantation (HSCT); Neutropenia; Neoplasms | Pfizer Europe Ma Eeig | 2010-06-07 | Hematopoietic stem cell transplantation (HSCT); Neutropenia; Neoplasms; Febrile Neutropenia | Details |
Recombinant human granulocyte colony stimulating Factor (Beijing Four Rings Bio-Pharmaceutical) | Approved | Beijing Four Rings Bio-Pharmaceutical Co Ltd | 欣粒生, Xin Lisheng | Mainland China | Neutropenia | Beijing Four Rings Bio-Pharmaceutical Co Ltd | 2002-06-17 | Neutropenia | Details | |
Pegfilgrastim biosimilar (Fresenius SE) | MSB-11455 | Approved | Merck Serono | Stimufend | EU | Chemotherapy-Induced Febrile Neutropenia; Neutropenia | Fresenius Kabi Deutschland Gmbh | 2022-03-28 | Chemotherapy-Induced Febrile Neutropenia; Neutropenia; Febrile Neutropenia | Details |
Filgrastim biosimilar (Zuventus Healthcare) | Approved | Zuventus Healthcare | India | Neutropenia | Zuventus Healthcare | 2012-08-01 | Neutropenia | Details | ||
Lenograstim biosimilar (Biosidus) | Approved | Biosidus | Lenobio, Leumostin, Lenograstim Biosidus | Neutropenia | Details | |||||
Lipegfilgrastim | XM-22 | Approved | Teva | Lonquex | EU | Neutropenia | Teva Bv | 2013-07-25 | Neutropenia | Details |
Filgrastim biosimilar (Neiss Labs) | Approved | Neiss Labs | Nisgras | India | Neutropenia | Neiss Labs | 2012-08-01 | Neutropenia | Details | |
Filgrastim biosimilar (Fuji Pharmaceutical/Mochida/Gene Techno Science) | GBS-001; FSK-0808 | Approved | Mochida Pharmaceutical Co Ltd, Gene Techno Science, Fuji Pharmaceutical | Japan | Neutropenia | Fuji Pharmaceutical | 2012-11-21 | Neutropenia | Details | |
Filgrastim biosimilar (Center of Molecular Immunology) | Approved | Center Of Molecular Immunology | ior-LeukoCIM | Cuba | Neutropenia | Center Of Molecular Immunology | 2016-01-14 | Neutropenia | Details | |
Lenograstim | rG-CSF | Approved | Chugai Pharmaceutical Co Ltd | 格拉诺赛特, Neutrogin, Granocyte | Japan | Neutropenia | Chugai Pharmaceutical Co Ltd | 1991-10-04 | Neutropenia; Hodgkin Disease; Multiple Myeloma; Lymphoma, Non-Hodgkin | Details |
Pegfilgrastim biosimilar (CinnaGen) | Approved | Cinnagen | PegaGen | Neutropenia | Details | |||||
Pegfilgrastim biosimilar (Emcure Pharmaceuticals) | Approved | Emcure Pharma | Neutropenia | Details | ||||||
Pegteograstim | MG-1107 | Approved | GC Biopharma Corp | Neulapeg | South Korea | Neutropenia | GC Biopharma Corp | 2014-01-01 | Neutropenia; Febrile Neutropenia | Details |
Filgrastim biosimilar (RAS Lifesciences) | Approved | Ras Lifesciences | India | Neutropenia | Ras Lifesciences | 2012-01-01 | Neutropenia | Details | ||
Filgrastim biosimilar (Sudershan Biotech) | Approved | Sudershan Biotech Ltd | Neutropenia | Details | ||||||
Filgrastim biosimilar (Shandong Quangang Pharmaceutical) | Approved | Shandong Quangang Pharmaceutical Co Ltd | 泉升, Quan Sheng | Mainland China | Neutropenia | Shandong Quangang Pharmaceutical Co Ltd | 2002-04-16 | Neutropenia | Details | |
Pegfilgrastim biosimilar (Qilu Pharmaceuticals) | PEG-rhG-CSF (Qilu Pharmaceuticals) | Approved | Qilu Pharmaceutical Co Ltd | 新瑞白 | Mainland China | Neutropenia | Qilu Pharmaceutical Co Ltd | 2015-08-08 | Neutropenia | Details |
Filgrastim biosimilar (RPG Life Sciences) | Approved | Rpg Life Sciences Ltd | Frastim | India | Neutropenia | Rpg Life Sciences Ltd | 2012-08-01 | Neutropenia | Details | |
Pegfilgrastim biosimilar (Sandoz) | LAEP-2006 | Approved | Clariant Produkte (Schweiz) Ag | Zioxtenzo, Ziextenzo | EU | Neutropenia | Sandoz Gmbh | 2018-11-22 | Neutropenia; Febrile Neutropenia | Details |
Telpegfilgrastim | YPEG-rhG-CSF | Approved | Xiamen Amoytop Biotech Co Ltd | 珮金 | Mainland China | Febrile Neutropenia | Xiamen Amoytop Biotech Co Ltd | 2023-06-30 | Neutropenia; Pre-Eclampsia; Febrile Neutropenia | Details |
Filgrastim biosimilar (Landsteiner) | Approved | Landsteiner Scientific | Biofilgran | Neutropenia | Details | |||||
Filgrastim biosimilar (Sandoz) | EP-2006 | Approved | Sandoz | Zarxio, Zarzio | EU | Chemotherapy-Induced Febrile Neutropenia; Neutropenia | Hexal Ag, Sandoz Gmbh | 2009-02-06 | Chemotherapy-Induced Febrile Neutropenia; Neutropenia; Febrile Neutropenia | Details |
Pegfilgrastim biosimilar (Cinfa Biotech) | B-12019 | Approved | Cinfa Biotech Gmbh | Pelmeg | EU | Neutropenia | Mundipharma Corporation (Ireland) Ltd | 2018-11-20 | Neutropenia | Details |
Filgrastim biosimilar (Pharmapark) | Approved | Pharmapark | Neutropenia | Pharmapark | 2008-01-01 | Neutropenia | Details | |||
Filgrastim biosimilar (NCPC GeneTech Biotechnology Development) | Approved | North China Pharmaceutical Company Ltd | GeSysin | Mainland China | Neutropenia | North China Pharmaceutical Company Ltd | 1999-01-01 | Neutropenia | Details | |
Pegfilgrastim biosimilar(Nora Pharma) | Approved | Nora Pharma Inc | NIOPEG | Canada | Febrile Neutropenia | Nora Pharma Inc | 2024-04-19 | Febrile Neutropenia | Details | |
Filgrastim biosimilar (Chengdu Institute of Biological Products) | Approved | Chengdu Institute Of Biological Products Co Ltd | 保力津, Baolijin | Mainland China | Neutropenia | Chengdu Institute Of Biological Products Co Ltd | 2001-01-01 | Neutropenia | Details | |
Pegfilgrastim biosimilar (mochida) | GBS-010; MD110 | Approved | Mochida Pharmaceutical Co Ltd | Japan | Febrile Neutropenia | Mochida Pharmaceutical Co Ltd | 2023-09-25 | Chemotherapy-Induced Febrile Neutropenia; Febrile Neutropenia | Details | |
Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor for Injection (Foshan Hanyu) | Approved | Foshan Hanyu Biopharmaceutical Co Ltd | 格宁 | Mainland China | Neutropenia | Foshan Hanyu Biopharmaceutical Co Ltd | 1998-01-01 | Neutropenia | Details | |
Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor for Injection (Beijing Beiyi Union) | Approved | Beijing Beiyi Union Pharmaceutical Co Ltd | 健白 | Mainland China | Neutropenia | Beijing Beiyi Union Pharmaceutical Co Ltd | 2002-05-08 | Neutropenia | Details | |
Recombinant human granulocyte macrophage colony stimulating factor (Kyowa Hakko Kirin) | Approved | Kyowa Kirin Co Ltd, Ise Plant, Nipro Pharma Corp, Kyowa Kirin China Pharmaceutical Co Ltd | Details | |||||||
Pegylated recombinant human granulocyte colony stimulating factor (Hangzhou Jiuyuan Gene) | JY06 | Approved | Hangzhou Jiuyuan Gene Engineering Co., Ltd. | 吉新芬 | Mainland China | Neutropenia | Hangzhou Jiuyuan Gene Engineering Co., Ltd. | 2025-01-14 | Neutropenia; Neoplasms; Febrile Neutropenia | Details |
Pegfilgrastim biosimilar(Shandong New Time Pharmaceutical ) | Approved | Shandong New Time Pharmaceutical Co Ltd | Details | |||||||
Pegfilgrastim biosimilar (Biocon/Mylan) | MYL-1401H | Approved | Biocon Ltd | Fulphila | United States | Febrile Neutropenia | Mylan Gmbh | 2018-06-04 | Chemotherapy-Induced Febrile Neutropenia; Neutropenia; Febrile Neutropenia | Details |
Pegfilgrastim biosimilar (Dong-A ST) | DA-3031 | Approved | Dong-A Pharmaceutical Co Ltd | Dulastin | South Korea | Neutropenia | Dong-A Pharmaceutical Co Ltd | 2014-01-01 | Neutropenia | Details |
Filgrastim biosimilar (CIGB/Heber Biotec) | Approved | Center For Genetic Engineering And Biotechnology, Heber Biotec | Hebervital | Neutropenia | null | 2009-01-01 | Neutropenia | Details | ||
Filgrastim biosimilar (Qilu Pharmaceutical) | Approved | Qilu Pharmaceutical Co Ltd | 瑞白 | Mainland China | Neutropenia | Qilu Pharmaceutical Co Ltd | 1999-01-01 | Neutropenia | Details | |
Molgramostim biosimilar (RAS Lifesciences) | Approved | Biomerieux | India | Neutropenia | Biomerieux | 2012-10-01 | Neutropenia | Details | ||
Pegylated recombinant human granulocyte colony stimulating factor (CSPC Pharma) | Approved | CSPC Pharmaceutical Group Ltd | 津优力, Pegleukim | Mainland China | Neutropenia | Cspc Baike (Shandong) Biopharmaceutical Co Ltd | 2011-10-21 | Neutropenia | Details | |
Filgrastim biosimilar (Dr Reddy's Laboratories) | Approved | Dr.Reddy's Laboratories Ltd | Grafeel | India | Neutropenia | Dr.Reddy's Laboratories Ltd | 2001-01-01 | Neutropenia | Details | |
Pegfilgrastim biosimilar (Adello Biologics) | TPI-120 | Approved | Adello Biologics Llc | FYLNETRA | United States | Febrile Neutropenia | Kashiv BioSciences LLC | 2022-05-26 | Neutropenia; Febrile Neutropenia | Details |
Pegfilgrastim biosimilar (Lupin) | Approved | Lupin Ltd | Lupifil-P | India | Neutropenia | Lupin Ltd | 2016-01-01 | Neutropenia | Details | |
Filgrastim biosimilar (Elea) | Approved | Elea | Neutropenia | Details | ||||||
Pegfilgrastim biosimilar (Accord Healthcare) | Approved | Accord Healthcare | Pelgraz | EU | Neutropenia | Accord Healthcare Slu | 2018-09-21 | Neutropenia | Details | |
Pegfilgrastim biosimilar (Dr Reddy's Laboratories) | DRL_PG | Approved | Dr.Reddy's Laboratories Ltd | Peg-grafeel | India | Neutropenia | Dr.Reddy's Laboratories Ltd | 2011-01-01 | Neutropenia | Details |
English Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Pegfilgrastim biosimilar (Reliance Life Sciences) | R-TPR-029 | Phase 3 Clinical | Reliance Life Sciences | Neutropenia | Details |
Filgrastim biosimilar (Bio-Ker) | BK-0023 | Phase 3 Clinical | Bio-Ker Srl | Neutropenia | Details |
Filgrastim biosimilar (Virchow Group) | Neutrogen | Phase 3 Clinical | Virchow Group | Neutropenia | Details |
Polyethylene Glycolized Human Granulocyte Stimulating Factor(Kexing Biopharm) | PEG-G-CSF(Kexing Biopharm) | Phase 3 Clinical | Kexing Biopharm Co Ltd | Chemotherapy-Induced Febrile Neutropenia; Breast Neoplasms | Details |
Filgrastim biosimilar(Blau Farmaceutica) | Phase 3 Clinical | Blau Farmaceutica Sa | Neutropenia | Details | |
G-CSF(GPCR Therapeutics) | G-CSF(GPCR Therapeutics) | Phase 3 Clinical | GPCR Therapeutics USA Inc | Hematopoietic stem cell transplantation (HSCT); Hemoglobinuria, Paroxysmal; Red-Cell Aplasia, Pure; Neuroblastoma; Anemia, Aplastic; Ganglioneuroblastoma; Thrombocytopenia | Details |
Pegylated human granulocyte colony stimulating factor (Sinovac Biotech) | Phase 3 Clinical | Shandong Kexing Bio-Products Co Ltd | Febrile Neutropenia | Details | |
Anumigilimab | CSL-324; CSL324 G-CSFR; CSL-324-G-CSFR | Phase 2 Clinical | Murigen, Zenyth Therapeutics Ltd | Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Psoriasis; Hidradenitis Suppurativa; Community Acquired Pneumonia | Details |
Pegfilgrastim ANF | PEG-G-CSF-ANF | Phase 2 Clinical | Prolong Pharmaceuticals Llc | Neutropenia | Details |
GM-CSF / IL3 fusion protein | Phase 2 Clinical | Shanghai Zhao'An Medical Technology Co Ltd, Beijing Igus Medical Technology Development Co Ltd | Neuroblastoma | Details | |
Recombinant Human Granulocyte Colony-Stimulating Factor(Children's Hospital of Soochow University) | Phase 2 Clinical | Children's Hospital of Soochow University | Leukemia, Myeloid, Acute | Details | |
JZB-27 | JZB-27 | Phase 2 Clinical | Shanghai Jingze Biotechnology Co Ltd, Hunan Jingfeng Pharmaceutical Co Ltd | Neutropenia | Details |
Albumin-granulocyte colony stimulating factor (Beijing BioFortune/Tianjin SinoBiotech) | SFR-9314; rHSA/GCSF | Phase 2 Clinical | Beijing Meifuyuan Biomedical Technology Co Ltd, Tianjin Puying Biotechnology Co Ltd | Chemotherapy-Induced Febrile Neutropenia; Neutropenia; Agranulocytosis | Details |
Filgrastim biosimilar (Biogenomics) | Phase 1 Clinical | Biogenomics | Neutropenia | Details | |
PEGylated G-CSF | BBT-015 | Phase 1 Clinical | Bolder Biotechnology | Neutropenia; Acute Radiation Syndrome | Details |
Pegfilgrastim biosimilar (Bio-Ker) | Phase 1 Clinical | Bio-Ker Srl | Neutropenia | Details | |
Pegfilgrastim biosimilar (Jiangsu Aosaikang Pharmaceutical) | Phase 1 Clinical | Jiangsu Aosaikang Pharmaceutical Co Ltd | Solid tumours | Details | |
Filgrastim biosimilar(Curateq Biologics) | BP13(Curateq Biologics); BP-13(Curateq Biologics) | Phase 1 Clinical | CuraTeQ Biologics Pvt Ltd | Febrile Neutropenia | Details |
Pegylated recombinant human granulocyte colony stimulating factor (Jiangnan University) | Phase 1 Clinical | Jiangnan University | Multiple Myeloma | Details | |
Pegfilgrastim biosimilar (Tanvex Biopharma) | TX-04 | Phase 1 Clinical | Tanvex Biopharma | Details | |
Granulocyte colony-stimulating factor(Kura Oncology Inc) | Phase 1 Clinical | Kura Oncology Inc | Leukemia; Leukemia, Myeloid; Hematologic Neoplasms; Neoplasms; Leukemia, Myeloid, Acute | Details | |
Recombinant human granulocyte-stimulating factor(Zhongnan Hospital) | Phase 1 Clinical | Zhongnan Hospital Of Wuhan University | Hematologic Neoplasms | Details | |
Polyethylene glycolized recombinant human granulocyte-stimulating factor(Zhongnan Hospital) | Phase 1 Clinical | Zhongnan Hospital Of Wuhan University | Hematologic Neoplasms | Details | |
Filgrastim biosimilar (MenoGenix) | MNGX-100 | Phase 1 Clinical | Menogenix Inc | Menopausal symptoms | Details |
Pegfilgrastim biosimilar (Megalabs) | Phase 1 Clinical | Megalabs | Neutropenia | Details | |
Pegfilgrastim biosimilar (Affiliated Hospital of North Sichuan Medical College) | Clinical | Affiliated Hospital Of North Sichuan Medical College | Neutropenia | Details | |
BSC-1020 | BSC-1020 | Clinical | Biosimilar Solutions Inc | Neoplasms | Details |
Long-acting Reconbinant human G-CSF(kexing) | GB-K02 | Clinical | Shandong Kexing Bio-Products Co Ltd | Neoplasms | Details |
BSC-0826 | BSC-0826 | Clinical | Biosimilar Solutions Inc | Neutropenia; Radiation Injuries | Details |
This web search service is supported by Google Inc.